Literature DB >> 28641977

A novel fluorescent probe reveals starvation controls the commitment of amyloid precursor protein to the lysosome.

Leanne K Hein1, Pirjo M Apaja2, Kathryn Hattersley3, Randall H Grose4, Jianling Xie5, Christopher G Proud6, Timothy J Sargeant7.   

Abstract

Alzheimer's disease is the most important cause of dementia but there is no therapy that has been demonstrated to stop or slow disease progression. Amyloid precursor protein (APP) is the source of amyloid-β (Aβ), which aggregates in Alzheimer's disease to form toxic oligomeric species. The endo-lysosomal system can clear APP and Aβ from the cell if these molecular species are trafficked through to the lysosome. Currently, there are no easy methods available for the analysis of lysosomal APP trafficking. We therefore generated a fusion protein (tandem-fluorescent, or tf-APP) that allows detection of changes in APP trafficking using accessible techniques such as flow cytometry. This permits rapid analysis or screening of genes and compounds that alter APP processing in the cell. Using our novel molecular probe, we determined that starvation induces trafficking of APP and APP-carboxy-terminal fragments (APP-CTFs) to the degradative endo-lysosomal network. In line with this finding, suppression of mTOR signalling using AZD8055 also strongly induced trafficking of APP to the endo-lysosomal system. Remarkably, activation of mTOR signalling via RHEB over-expression inhibited the starvation-induced autophagy but did not affect trafficking of tf-APP. These results show tf-APP can be used to determine how APP is trafficked through the lysosomal system of the cell. This molecular probe is therefore useful for determining the molecular mechanism behind the commitment of APP to the degradative pathway or for screening compounds that can induce this effect. This is important as clearance of APP and APP-CTF provides an important potential therapeutic strategy for Alzheimer's disease.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid precursor protein; Endocytosis; Lysosome; Starvation; mTOR

Mesh:

Substances:

Year:  2017        PMID: 28641977     DOI: 10.1016/j.bbamcr.2017.06.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  5 in total

1.  TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodelling.

Authors:  Jianling Xie; Stuart P De Poi; Sean J Humphrey; Leanne K Hein; John B Bruning; Wenru Pan; Luke A Selth; Timothy J Sargeant; Christopher G Proud
Journal:  Cell Mol Life Sci       Date:  2021-04-08       Impact factor: 9.261

2.  Measurement of autophagic flux in humans: an optimized method for blood samples.

Authors:  Julien Bensalem; Kathryn J Hattersley; Leanne K Hein; Xiao Tong Teong; Julian M Carosi; Sofia Hassiotis; Randall H Grose; Célia Fourrier; Leonie K Heilbronn; Timothy J Sargeant
Journal:  Autophagy       Date:  2020-12-11       Impact factor: 16.016

Review 3.  Possible Clues for Brain Energy Translation via Endolysosomal Trafficking of APP-CTFs in Alzheimer's Disease.

Authors:  Senthilkumar Sivanesan; Ravi Mundugaru; Jayakumar Rajadas
Journal:  Oxid Med Cell Longev       Date:  2018-10-21       Impact factor: 6.543

Review 4.  Natural Products in Therapeutic Management of Multineurodegenerative Disorders by Targeting Autophagy.

Authors:  Sibhghatulla Shaikh; Khurshid Ahmad; Syed Sayeed Ahmad; Eun Ju Lee; Jeong Ho Lim; Mirza Masroor Ali Beg; Amit K Verma; Inho Choi
Journal:  Oxid Med Cell Longev       Date:  2021-09-13       Impact factor: 6.543

5.  Retromer regulates the lysosomal clearance of MAPT/tau.

Authors:  Julian M Carosi; Leanne K Hein; Mark van den Hurk; Robert Adams; Bridget Milky; Sanjna Singh; Cedric Bardy; Donna Denton; Sharad Kumar; Timothy J Sargeant
Journal:  Autophagy       Date:  2020-09-22       Impact factor: 16.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.